Yair Holtzman

Yair Holtzman

Latest from Yair Holtzman

The U.S. Medical Device Industry: Strengths, Weaknesses, Opportunities, and Threats
Business
The U.S. Medical Device Industry: Strengths, Weaknesses, Opportunities, and ThreatsThe U.S. Medical Device Industry: Strengths, Weaknesses, Opportunities, and Threats
byYair Holtzman, Gleb Gorkhoverand 1 more
Jan 12, 2015
13 Min Read
The U.S. Medical Device Industry in 2012: Challenges at Home and Abroad
General Hospital
The U.S. Medical Device Industry in 2012: Challenges at Home and AbroadThe U.S. Medical Device Industry in 2012: Challenges at Home and Abroad
byYair Holtzman
Jul 17, 2012
17 Min Read

All from Yair Holtzman

Future Risks: How Biomedical Companies Navigated Turbulent Economic Times
Business
Future Risks: How Biomedical Companies Navigated Turbulent Economic Times
Future Risks: How Biomedical Companies Navigated Turbulent Economic Times
Jan 30, 2012
|
6 Min Read
byYair Holtzman, Tom Figgatt
Key Challenges: How Biomedical Companies Navigated Turbulent Economic Times
Business
Key Challenges: How Biomedical Companies Navigated Turbulent Economic Times
Key Challenges: How Biomedical Companies Navigated Turbulent Economic Times
Jan 30, 2012
|
13 Min Read
byYair Holtzman, Tom Figgatt
R&D and Investment: How Biomedical Companies Navigated Turbulent Economic Times
R&D
R&D and Investment: How Biomedical Companies Navigated Turbulent Economic Times
R&D and Investment: How Biomedical Companies Navigated Turbulent Economic Times
Jan 30, 2012
|
11 Min Read
byYair Holtzman, Tom Figgatt
How Biomedical Companies Navigated Turbulent Economic Times
IVD
How Biomedical Companies Navigated Turbulent Economic Times
How Biomedical Companies Navigated Turbulent Economic Times
Jan 30, 2012
|
11 Min Read
byYair Holtzman, Tom Figgatt
Approach and Methodology: How Biomedical Companies Successfully Navigated Turbulent Economic Times
Business
Approach and Methodology: How Biomedical Companies Successfully Navigated Turbulent Economic Times
Approach and Methodology: How Biomedical Companies Successfully Navigated Turbulent Economic Times
Jan 30, 2012
|
4 Min Read
byYair Holtzman, Tom Figgatt

Editors' Choice

Recall
Regulatory & Quality
Elekta Disposable Biopsy Needle Recall Identified as Class I
Elekta Disposable Biopsy Needle Recall Identified as Class I

Apr 26, 2024

Q&A
Digital Health
Identifying the Privacy & Ethical Pitfalls in Connected Medical Devices
Identifying the Privacy & Ethical Pitfalls in Connected Medical Devices

Apr 26, 2024

M&A
A New Vision for Pixium’s Retinal Implants
Science Corporation to Acquire Pixium's Retinal Implants

Apr 26, 2024

Recent Headlines
Sign up for the QMED & MD+DI Daily newsletter.